IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 18 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,784,734 | -1.6% | 19,017,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $19,092,318 | -61.6% | 19,017,000 | -61.6% | 0.00% | -63.6% |
| Q1 2023 | $49,715,028 | -39.7% | 49,517,000 | -35.3% | 0.01% | -42.1% |
| Q4 2022 | $82,494,920 | -1.6% | 76,517,000 | -8.4% | 0.02% | 0.0% |
| Q3 2022 | $83,864,000 | -14.6% | 83,550,000 | -10.3% | 0.02% | -24.0% |
| Q2 2022 | $98,152,000 | -2.8% | 93,100,000 | +3.3% | 0.02% | +19.0% |
| Q1 2022 | $101,021,000 | +1.0% | 90,100,000 | 0.0% | 0.02% | +5.0% |
| Q4 2021 | $100,067,000 | +0.2% | 90,100,000 | +6.2% | 0.02% | -4.8% |
| Q3 2021 | $99,833,000 | +0.3% | 84,800,000 | 0.0% | 0.02% | -4.5% |
| Q2 2021 | $99,519,000 | +6.3% | 84,800,000 | 0.0% | 0.02% | -4.3% |
| Q1 2021 | $93,634,000 | +13.1% | 84,800,000 | +14.9% | 0.02% | +4.5% |
| Q4 2020 | $82,810,000 | +21.9% | 73,800,000 | +7.3% | 0.02% | +15.8% |
| Q3 2020 | $67,923,000 | – | 68,800,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 30,477,080 | $31,017,758 | 1.54% |
| SHENKMAN CAPITAL MANAGEMENT INC | 17,691,000 | $17,931,726 | 1.34% |
| BRAIDWELL LP | 37,509,000 | $37,250,188 | 1.18% |
| III Capital Management | 16,200,000 | $16,068,483 | 0.81% |
| DLD Asset Management, LP | 7,500,000 | $7,471,875 | 0.80% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 34,375,000 | $34,057,674 | 0.73% |
| Worth Venture Partners, LLC | 1,034,000 | $1,029,476 | 0.61% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 40,200,000 | $39,922,620 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 3,055,000 | $3,041,634 | 0.07% |
| Leucadia National | 7,149,000 | $7,051,572 | 0.06% |